source
- Dr Mauro on the Significance of Alternative TKI Formulations in CMLMichael Mauro, MD, details the FDA approval of the small-molecule formulation of dasatinib and other alternate TKI formulations in chronic myeloid leukemia.onclive · 3mo ago↗ source
- Sarepta tumbles as its gene therapy sales decline furtherEven though Elevidys beat Wall Street expectations, analysts expect investor focus to shift toward Sarepta's early-stage RNA drugs.BioPharma Dive · 3mo ago↗ source
- Key takeaways from WHO briefing on hantavirus cruise ship outbreakHere are key takeaways from a WHO briefing on the hantavirus outbreak aboard a cruise ship.STAT · 3mo ago↗ source